Ovarian sex cord-stromal tumors: an update on clinical features, molecular changes, and management

Area of Science:

• Gynecologic Oncology
• Pathology
• Molecular Biology

Background:

• Sex cord-stromal tumors are rare ovarian neoplasms with diverse histological features and behaviors.
• Current management relies primarily on surgery, with chemotherapy and hormonal therapy for advanced or recurrent cases.
• Understanding the molecular underpinnings of these tumors is crucial for improved diagnostics and therapeutics.

Purpose of the Study:

• To provide a comprehensive update on the clinical presentation of sex cord-stromal tumors.
• To review the current understanding of molecular alterations in various sex cord-stromal tumor subtypes.
• To summarize contemporary management strategies and potential therapeutic targets.

Main Methods:

• Literature review of clinical, molecular, and therapeutic studies on sex cord-stromal tumors.
• Synthesis of information on tumor subtypes, diagnostic criteria, and prognostic factors.
• Analysis of recent advancements in molecular profiling and targeted therapies.

Main Results:

• Sex cord-stromal tumors encompass a spectrum of entities including granulosa cell tumors, Sertoli-Leydig cell tumors, and others.
• Key molecular pathways and genetic alterations implicated in tumorigenesis are being elucidated.
• Emerging data suggests potential for targeted therapies based on specific molecular profiles.

Conclusions:

• Accurate diagnosis and molecular characterization are essential for effective management of sex cord-stromal tumors.
• Further research into molecular changes will identify novel biomarkers and therapeutic strategies.
• An integrated approach combining clinical, pathological, and molecular data optimizes patient outcomes.